-
1
-
-
81355139605
-
Cannabinoid-opioid interaction in chronic pain
-
Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL (2011). Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther 90: 844–851.
-
(2011)
Clin Pharmacol Ther
, vol.90
, pp. 844-851
-
-
Abrams, D.I.1
Couey, P.2
Shade, S.B.3
Kelly, M.E.4
Benowitz, N.L.5
-
2
-
-
84976528239
-
Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
-
Albert-Vartanian A, Boyd MR, Hall AL, Morgado SJ, Nguyen E, Nguyen VP et al. (2016). Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? J Clin Pharm Ther 41: 371–382.
-
(2016)
J Clin Pharm Ther
, vol.41
, pp. 371-382
-
-
Albert-Vartanian, A.1
Boyd, M.R.2
Hall, A.L.3
Morgado, S.J.4
Nguyen, E.5
Nguyen, V.P.6
-
3
-
-
84949801835
-
The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
-
Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
-
(2015)
Br J Pharmacol
, vol.172
, pp. 5744-5869
-
-
Alexander, S.P.H.1
Davenport, A.P.2
Kelly, E.3
Marrion, N.4
Peters, J.A.5
Benson, H.E.6
-
4
-
-
84955254347
-
Primary care patients with drug use report chronic pain and self-medicate with alcohol and other drugs
-
Alford DP, German JS, Samet JH, Cheng DM, Lloyd-Travaglini CA, Saitz R (2016). Primary care patients with drug use report chronic pain and self-medicate with alcohol and other drugs. J Gen Intern Med 31: 486–491.
-
(2016)
J Gen Intern Med
, vol.31
, pp. 486-491
-
-
Alford, D.P.1
German, J.S.2
Samet, J.H.3
Cheng, D.M.4
Lloyd-Travaglini, C.A.5
Saitz, R.6
-
5
-
-
84940545408
-
Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward
-
Al-Hasani R, McCall JG, Shin G, Gomez AM, Schmitz GP, Bernardi JM et al. (2015). Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron 87: 1063–1077.
-
(2015)
Neuron
, vol.87
, pp. 1063-1077
-
-
Al-Hasani, R.1
McCall, J.G.2
Shin, G.3
Gomez, A.M.4
Schmitz, G.P.5
Bernardi, J.M.6
-
7
-
-
80051986275
-
Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review
-
Amari E, Rehm J, Goldner E, Fischer B (2011). Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry 56: 495–502.
-
(2011)
Can J Psychiatry
, vol.56
, pp. 495-502
-
-
Amari, E.1
Rehm, J.2
Goldner, E.3
Fischer, B.4
-
8
-
-
84857884111
-
-
[Online], (accessed 1/16/17)
-
Australian Government Department of Health, Therapeutic Goods Administration (2008). Best Practice Guideline on Prescription Medicine Labelling. [Online] Available at: https://www.tga.gov.au/publication/best-practice-guideline-prescription-medicine-labelling (accessed 1/16/17).
-
(2008)
Best Practice Guideline on Prescription Medicine Labelling
-
-
-
9
-
-
67649541074
-
Prescription opioid aberrant behaviors: a pilot study of sex differences
-
Back SE, Payne RA, Waldrop AE, Smith A, Reeves S, Brady KT (2009). Prescription opioid aberrant behaviors: a pilot study of sex differences. Clin J Pain 25: 477–484.
-
(2009)
Clin J Pain
, vol.25
, pp. 477-484
-
-
Back, S.E.1
Payne, R.A.2
Waldrop, A.E.3
Smith, A.4
Reeves, S.5
Brady, K.T.6
-
10
-
-
0242658912
-
Opioid therapy for chronic pain
-
Ballantyne JC, Mao J (2003). Opioid therapy for chronic pain. N Engl J Med 349: 1943–1953.
-
(2003)
N Engl J Med
, vol.349
, pp. 1943-1953
-
-
Ballantyne, J.C.1
Mao, J.2
-
11
-
-
84930517040
-
Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis
-
Bawa FL, Mercer SW, Atherton RJ, Clague F, Keen A, Scott NW et al. (2015). Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis. Br J Gen Pract 65: e387–e400.
-
(2015)
Br J Gen Pract
, vol.65
, pp. e387-e400
-
-
Bawa, F.L.1
Mercer, S.W.2
Atherton, R.J.3
Clague, F.4
Keen, A.5
Scott, N.W.6
-
12
-
-
84862338136
-
Cerebral interactions of pain and reward and their relevance for chronic pain
-
Becker S, Gandhi W, Schweinhardt P (2012). Cerebral interactions of pain and reward and their relevance for chronic pain. Neurosci Lett 520: 182–187.
-
(2012)
Neurosci Lett
, vol.520
, pp. 182-187
-
-
Becker, S.1
Gandhi, W.2
Schweinhardt, P.3
-
13
-
-
85048983764
-
-
[Online], (accessed January 16
-
Best Practice Guideline on Prescription Medicine Labelling. [Online] Available at https://www.tga.gov.au/publication/best-practice-guideline-prescription-medicine-labelling. (accessed January 16, 2017a).
-
(2017)
Best Practice Guideline on Prescription Medicine Labelling
-
-
-
14
-
-
84964297917
-
Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain
-
Boehnke KF, Litinas E, Clauw DJ (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain 17: 739–744.
-
(2016)
J Pain
, vol.17
, pp. 739-744
-
-
Boehnke, K.F.1
Litinas, E.2
Clauw, D.J.3
-
15
-
-
85048980179
-
-
[Online], on PDMP Effectiveness 3rd revision.pdf (accessed January 16
-
Briefing on PDMP Effectiveness. [Online] Available at: http://www.pdmpassist.org/pdf/COE_documents/Add_to_TTAC/Briefing on PDMP Effectiveness 3rd revision.pdf (accessed January 16, 2017b).
-
(2017)
Briefing on PDMP Effectiveness
-
-
-
16
-
-
34247523880
-
Development and validation of the current opioid misuse measure
-
Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N et al. (2007). Development and validation of the current opioid misuse measure. Pain 130: 144–156.
-
(2007)
Pain
, vol.130
, pp. 144-156
-
-
Butler, S.F.1
Budman, S.H.2
Fernandez, K.C.3
Houle, B.4
Benoit, C.5
Katz, N.6
-
17
-
-
84887994707
-
APS 1995 presidential address
-
Campbell JN (1995). APS 1995 presidential address. J Pain 5: 85–88.
-
(1995)
J Pain
, vol.5
, pp. 85-88
-
-
Campbell, J.N.1
-
18
-
-
84856506438
-
CDC grand rounds: prescription drug overdoses – a U.S. epidemic
-
Centers for Disease Control and Prevention (2012). CDC grand rounds: prescription drug overdoses – a U.S. epidemic. MMWR Morb Mortal Wkly Rep 61: 10–13.
-
(2012)
MMWR Morb Mortal Wkly Rep
, vol.61
, pp. 10-13
-
-
-
19
-
-
0030991539
-
Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors
-
Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E (1997). Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 13: 150–155.
-
(1997)
Clin J Pain
, vol.13
, pp. 150-155
-
-
Chabal, C.1
Erjavec, M.K.2
Jacobson, L.3
Mariano, A.4
Chaney, E.5
-
20
-
-
69249143742
-
2009 clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?
-
Chou R (2009). 2009 clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice? Pol Arch Med Wewn 119: 469–477.
-
(2009)
Pol Arch Med Wewn
, vol.119
, pp. 469-477
-
-
Chou, R.1
-
21
-
-
84923306081
-
-
[Online], (accessed 1/16/2017)
-
Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik J (2014). The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Agency for Healthcare Research and Quality: Rockville, MD. [Online] Available at: http://www.ahrq.gov/research/findings/evidence-based-reports/opoidstp.html (accessed 1/16/2017).
-
(2014)
The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Agency for Healthcare Research and Quality: Rockville, MD.
-
-
Chou, R.1
Deyo, R.2
Devine, B.3
Hansen, R.4
Sullivan, S.5
Jarvik, J.6
-
22
-
-
84946059139
-
Shifting patterns of prescription opioid and heroin abuse in the United States
-
Cicero TJ, Ellis MS, Harney J (2015). Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med 373: 1789–1790.
-
(2015)
N Engl J Med
, vol.373
, pp. 1789-1790
-
-
Cicero, T.J.1
Ellis, M.S.2
Harney, J.3
-
23
-
-
0037373238
-
Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration
-
Cichewicz DL, McCarthy EA (2003). Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther 304: 1010–1015.
-
(2003)
J Pharmacol Exp Ther
, vol.304
, pp. 1010-1015
-
-
Cichewicz, D.L.1
McCarthy, E.A.2
-
24
-
-
0032415875
-
Screening for addiction in patients with chronic pain and ‘problematic’ substance use: evaluation of a pilot assessment tool
-
Compton P, Darakjian J, Miotto K (1998). Screening for addiction in patients with chronic pain and ‘problematic’ substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 16: 355–363.
-
(1998)
J Pain Symptom Manage
, vol.16
, pp. 355-363
-
-
Compton, P.1
Darakjian, J.2
Miotto, K.3
-
25
-
-
84918831469
-
Packaging interventions to increase medication adherence: systematic review and meta-analysis
-
Conn VS, Ruppar TM, Chan KC, Dunbar-Jacob J, Pepper GA, De Geest S (2015). Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin 31: 145–160.
-
(2015)
Curr Med Res Opin
, vol.31
, pp. 145-160
-
-
Conn, V.S.1
Ruppar, T.M.2
Chan, K.C.3
Dunbar-Jacob, J.4
Pepper, G.A.5
De Geest, S.6
-
26
-
-
34648829826
-
Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence
-
Copenhaver MM, Bruce RD, Altice FL (2007). Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence. Am J Drug Alcohol Abuse 33: 643–654.
-
(2007)
Am J Drug Alcohol Abuse
, vol.33
, pp. 643-654
-
-
Copenhaver, M.M.1
Bruce, R.D.2
Altice, F.L.3
-
27
-
-
34249108566
-
Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat
-
Cox ML, Haller VL, Welch SP (2007). Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat. Eur J Pharmacol 567: 125–130.
-
(2007)
Eur J Pharmacol
, vol.567
, pp. 125-130
-
-
Cox, M.L.1
Haller, V.L.2
Welch, S.P.3
-
28
-
-
84941877027
-
Smartphone and mobile application utilization prior to and following treatment among individuals enrolled in residential substance use treatment
-
Dahne J, Lejuez CW (2015). Smartphone and mobile application utilization prior to and following treatment among individuals enrolled in residential substance use treatment. J Subst Abuse Treat 58: 95–99.
-
(2015)
J Subst Abuse Treat
, vol.58
, pp. 95-99
-
-
Dahne, J.1
Lejuez, C.W.2
-
29
-
-
84942744640
-
Impact of chronic pain on treatment prognosis for patients with opioid use disorder: a systematic review and meta-analysis
-
Dennis BB, Bawor M, Naji L, Chan CK, Varenbut J, Paul J et al. (2015). Impact of chronic pain on treatment prognosis for patients with opioid use disorder: a systematic review and meta-analysis. Subst Abuse 9: 59–80.
-
(2015)
Subst Abuse
, vol.9
, pp. 59-80
-
-
Dennis, B.B.1
Bawor, M.2
Naji, L.3
Chan, C.K.4
Varenbut, J.5
Paul, J.6
-
30
-
-
0027847675
-
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies
-
Devine DP, Leone P, Pocock D, Wise RA (1993). Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266: 1236–1246.
-
(1993)
J Pharmacol Exp Ther
, vol.266
, pp. 1236-1246
-
-
Devine, D.P.1
Leone, P.2
Pocock, D.3
Wise, R.A.4
-
31
-
-
84942083756
-
Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system
-
Donahue RJ, Landino SM, Golden SA, Carroll FI, Russo SJ, Carlezon WA Jr (2015). Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system. Behav Pharmacol 26: 654–663.
-
(2015)
Behav Pharmacol
, vol.26
, pp. 654-663
-
-
Donahue, R.J.1
Landino, S.M.2
Golden, S.A.3
Carroll, F.I.4
Russo, S.J.5
Carlezon, W.A.6
-
32
-
-
84888640391
-
A blueprint of pain curriculum across prelicensure health sciences programs: one NIH Pain Consortium Center of Excellence in Pain Education (CoEPE) experience
-
Doorenbos AZ, Gordon DB, Tauben D, Palisoc J, Drangsholt M, Lindhorst T et al. (2013). A blueprint of pain curriculum across prelicensure health sciences programs: one NIH Pain Consortium Center of Excellence in Pain Education (CoEPE) experience. J Pain 14: 1533–1538.
-
(2013)
J Pain
, vol.14
, pp. 1533-1538
-
-
Doorenbos, A.Z.1
Gordon, D.B.2
Tauben, D.3
Palisoc, J.4
Drangsholt, M.5
Lindhorst, T.6
-
33
-
-
84964402250
-
CDC guideline for prescribing opioids for chronic pain – United States, 2016
-
Dowell D, Haegerich TM, Chou R (2016). CDC guideline for prescribing opioids for chronic pain – United States, 2016. JAMA 315: 1624–1645.
-
(2016)
JAMA
, vol.315
, pp. 1624-1645
-
-
Dowell, D.1
Haegerich, T.M.2
Chou, R.3
-
34
-
-
84985032686
-
Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting
-
Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K et al. (2016). Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting. J Subst Abuse Treat 71: 1–7.
-
(2016)
J Subst Abuse Treat
, vol.71
, pp. 1-7
-
-
Dunn, K.E.1
Barrett, F.S.2
Yepez-Laubach, C.3
Meyer, A.C.4
Hruska, B.J.5
Petrush, K.6
-
35
-
-
84979202573
-
Innovative program targets five common pain syndromes with non-opioid alternatives
-
ED Management (2016). Innovative program targets five common pain syndromes with non-opioid alternatives. ED Manag 28: 61–66.
-
(2016)
ED Manag
, vol.28
, pp. 61-66
-
-
-
36
-
-
84941756577
-
Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons
-
Ehrich JM, Messinger DI, Knakal CR, Kuhar JR, Schattauer SS, Bruchas MR et al. (2015). Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons. J Neurosci 35: 12917–12931.
-
(2015)
J Neurosci
, vol.35
, pp. 12917-12931
-
-
Ehrich, J.M.1
Messinger, D.I.2
Knakal, C.R.3
Kuhar, J.R.4
Schattauer, S.S.5
Bruchas, M.R.6
-
37
-
-
44249119043
-
What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review
-
Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS (2008). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 9: 444–459.
-
(2008)
Pain Med
, vol.9
, pp. 444-459
-
-
Fishbain, D.A.1
Cole, B.2
Lewis, J.3
Rosomoff, H.L.4
Rosomoff, R.S.5
-
38
-
-
84889659843
-
The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways
-
Garland EL, Froeliger B, Zeidan F, Partin K, Howard MO (2013). The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways. Neurosci Biobehav Rev 37: 2597–2607.
-
(2013)
Neurosci Biobehav Rev
, vol.37
, pp. 2597-2607
-
-
Garland, E.L.1
Froeliger, B.2
Zeidan, F.3
Partin, K.4
Howard, M.O.5
-
39
-
-
84876021379
-
Attenuation of cocaine and heroin seeking by mu-opioid receptor antagonism
-
Giuliano C, Robbins TW, Wille DR, Bullmore ET, Everitt BJ (2013). Attenuation of cocaine and heroin seeking by mu-opioid receptor antagonism. Psychopharmacology (Berl) 227: 137–147.
-
(2013)
Psychopharmacology (Berl)
, vol.227
, pp. 137-147
-
-
Giuliano, C.1
Robbins, T.W.2
Wille, D.R.3
Bullmore, E.T.4
Everitt, B.J.5
-
40
-
-
80051783998
-
Improving temporal efficiency of outpatient buprenorphine induction
-
Gunderson EW, Levin FR, Rombone MM, Vosburg SK, Kleber HD (2011). Improving temporal efficiency of outpatient buprenorphine induction. Am J Addict 20: 397–404.
-
(2011)
Am J Addict
, vol.20
, pp. 397-404
-
-
Gunderson, E.W.1
Levin, F.R.2
Rombone, M.M.3
Vosburg, S.K.4
Kleber, H.D.5
-
41
-
-
84941089593
-
Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1
-
Hancock DB, Levy JL, Gaddis NC, Glasheen C, Saccone NL, Page GP et al. (2015). Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1. Biol Psychiatry 78: 474–484.
-
(2015)
Biol Psychiatry
, vol.78
, pp. 474-484
-
-
Hancock, D.B.1
Levy, J.L.2
Gaddis, N.C.3
Glasheen, C.4
Saccone, N.L.5
Page, G.P.6
-
42
-
-
84958787528
-
The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: a prospective open-label study
-
Haroutounian S, Ratz Y, Ginosar Y, Furmanov K, Saifi F, Meidan R et al. (2016). The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: a prospective open-label study. Clin J Pain 32: 1036–1043.
-
(2016)
Clin J Pain
, vol.32
, pp. 1036-1043
-
-
Haroutounian, S.1
Ratz, Y.2
Ginosar, Y.3
Furmanov, K.4
Saifi, F.5
Meidan, R.6
-
43
-
-
84866491179
-
Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update
-
Harris PE, Cooper KL, Relton C, Thomas KJ (2012). Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract 66: 924–939.
-
(2012)
Int J Clin Pract
, vol.66
, pp. 924-939
-
-
Harris, P.E.1
Cooper, K.L.2
Relton, C.3
Thomas, K.J.4
-
45
-
-
84940952898
-
Inflammatory pain promotes increased opioid self-administration: role of dysregulated ventral tegmental area mu opioid receptors
-
Hipolito L, Wilson-Poe A, Campos-Jurado Y, Zhong E, Gonzalez-Romero J, Virag L et al. (2015). Inflammatory pain promotes increased opioid self-administration: role of dysregulated ventral tegmental area mu opioid receptors. J Neurosci 35: 12217–12231.
-
(2015)
J Neurosci
, vol.35
, pp. 12217-12231
-
-
Hipolito, L.1
Wilson-Poe, A.2
Campos-Jurado, Y.3
Zhong, E.4
Gonzalez-Romero, J.5
Virag, L.6
-
47
-
-
85027929537
-
A randomized trial of a pain management intervention for adults receiving substance use disorder treatment
-
Ilgen MA, Bohnert AS, Chermack S, Conran C, Jannausch M, Trafton J et al. (2016). A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction 111: 1385–1393.
-
(2016)
Addiction
, vol.111
, pp. 1385-1393
-
-
Ilgen, M.A.1
Bohnert, A.S.2
Chermack, S.3
Conran, C.4
Jannausch, M.5
Trafton, J.6
-
49
-
-
0033955297
-
Characteristics of methadone maintenance patients with chronic pain
-
Jamison RN, Kauffman J, Katz NP (2000). Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 19: 53–62.
-
(2000)
J Pain Symptom Manage
, vol.19
, pp. 53-62
-
-
Jamison, R.N.1
Kauffman, J.2
Katz, N.P.3
-
50
-
-
78149285273
-
The prevalence of chronic pain in United States adults: results of an Internet-based survey
-
Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH (2010). The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain 11: 1230–1239.
-
(2010)
J Pain
, vol.11
, pp. 1230-1239
-
-
Johannes, C.B.1
Le, T.K.2
Zhou, X.3
Johnston, J.A.4
Dworkin, R.H.5
-
51
-
-
84882452814
-
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics
-
Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT (2013). An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage 46: 207–218.
-
(2013)
J Pain Symptom Manage
, vol.46
, pp. 207-218
-
-
Johnson, J.R.1
Lossignol, D.2
Burnell-Nugent, M.3
Fallon, M.T.4
-
52
-
-
84979261573
-
Opioid and cannabinoid synergy in a mouse neuropathic pain model
-
Kazantzis NP, Casey SL, Seow PW, Mitchell VA, Vaughan CW (2016). Opioid and cannabinoid synergy in a mouse neuropathic pain model. Br J Pharmacol 173: 2521–2531.
-
(2016)
Br J Pharmacol
, vol.173
, pp. 2521-2531
-
-
Kazantzis, N.P.1
Casey, S.L.2
Seow, P.W.3
Mitchell, V.A.4
Vaughan, C.W.5
-
55
-
-
84876310253
-
Injectable, cellular-scale optoelectronics with applications for wireless optogenetics
-
Kim TI, McCall JG, Jung YH, Huang X, Siuda ER, Li Y et al. (2013). Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340: 211–216.
-
(2013)
Science
, vol.340
, pp. 211-216
-
-
Kim, T.I.1
McCall, J.G.2
Jung, Y.H.3
Huang, X.4
Siuda, E.R.5
Li, Y.6
-
56
-
-
70349110145
-
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain
-
Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL et al. (2009). Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther 330: 902–910.
-
(2009)
J Pharmacol Exp Ther
, vol.330
, pp. 902-910
-
-
Kinsey, S.G.1
Long, J.Z.2
O'Neal, S.T.3
Abdullah, R.A.4
Poklis, J.L.5
Boger, D.L.6
-
57
-
-
0037407734
-
Management of drug and alcohol withdrawal
-
Kosten TR, O'Connor PG (2003). Management of drug and alcohol withdrawal. N Engl J Med 348: 1786–1795.
-
(2003)
N Engl J Med
, vol.348
, pp. 1786-1795
-
-
Kosten, T.R.1
O'Connor, P.G.2
-
58
-
-
73149124507
-
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking
-
Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D et al. (2009). Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A 106: 19168–19173.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 19168-19173
-
-
Land, B.B.1
Bruchas, M.R.2
Schattauer, S.3
Giardino, W.J.4
Aita, M.5
Messinger, D.6
-
59
-
-
79955641980
-
Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours
-
Larance B, Degenhardt L, Lintzeris N, Winstock A, Mattick R (2011). Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev 30: 236–245.
-
(2011)
Drug Alcohol Rev
, vol.30
, pp. 236-245
-
-
Larance, B.1
Degenhardt, L.2
Lintzeris, N.3
Winstock, A.4
Mattick, R.5
-
61
-
-
84930762521
-
Prescription drug monitoring and drug overdose mortality
-
Li G, Brady JE, Lang BH, Giglio J, Wunsch H, DiMaggio C (2014). Prescription drug monitoring and drug overdose mortality. Inj Epidemiol 1: 9.
-
(2014)
Inj Epidemiol
, vol.1
, pp. 9
-
-
Li, G.1
Brady, J.E.2
Lang, B.H.3
Giglio, J.4
Wunsch, H.5
DiMaggio, C.6
-
62
-
-
84897019944
-
Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia
-
Loggia ML, Berna C, Kim J, Cahalan CM, Gollub RL, Wasan AD et al. (2014). Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia. Arthritis Rheumatol 66: 203–212.
-
(2014)
Arthritis Rheumatol
, vol.66
, pp. 203-212
-
-
Loggia, M.L.1
Berna, C.2
Kim, J.3
Cahalan, C.M.4
Gollub, R.L.5
Wasan, A.D.6
-
63
-
-
84984612101
-
Structure-based discovery of opioid analgesics with reduced side effects
-
Manglik A, Lin H, Aryal DK, McCorvy JD, Dengler D, Corder G et al. (2016). Structure-based discovery of opioid analgesics with reduced side effects. Nature 537: 185–190.
-
(2016)
Nature
, vol.537
, pp. 185-190
-
-
Manglik, A.1
Lin, H.2
Aryal, D.K.3
McCorvy, J.D.4
Dengler, D.5
Corder, G.6
-
64
-
-
84937242988
-
Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States
-
Mars SG, Fessel JN, Bourgois P, Montero F, Karandinos G, Ciccarone D (2015). Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States. Soc Sci Med 140: 44–53.
-
(2015)
Soc Sci Med
, vol.140
, pp. 44-53
-
-
Mars, S.G.1
Fessel, J.N.2
Bourgois, P.3
Montero, F.4
Karandinos, G.5
Ciccarone, D.6
-
65
-
-
33846939014
-
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction
-
Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR et al. (2007). Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146: 116–127.
-
(2007)
Ann Intern Med
, vol.146
, pp. 116-127
-
-
Martell, B.A.1
O'Connor, P.G.2
Kerns, R.D.3
Becker, W.C.4
Morales, K.H.5
Kosten, T.R.6
-
66
-
-
84936881487
-
Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum
-
Martikainen IK, Nuechterlein EB, Pecina M, Love TM, Cummiford CM, Green CR et al. (2015). Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum. J Neurosci 35: 9957–9965.
-
(2015)
J Neurosci
, vol.35
, pp. 9957-9965
-
-
Martikainen, I.K.1
Nuechterlein, E.B.2
Pecina, M.3
Love, T.M.4
Cummiford, C.M.5
Green, C.R.6
-
67
-
-
0035783703
-
Changes in reward-induced brain activation in opiate addicts
-
Martin-Soelch C, Chevalley AF, Kunig G, Missimer J, Magyar S, Mino A et al. (2001). Changes in reward-induced brain activation in opiate addicts. Eur J Neurosci 14: 1360–1368.
-
(2001)
Eur J Neurosci
, vol.14
, pp. 1360-1368
-
-
Martin-Soelch, C.1
Chevalley, A.F.2
Kunig, G.3
Missimer, J.4
Magyar, S.5
Mino, A.6
-
68
-
-
84946423565
-
Prescription monitoring programs and emergency department visits involving opioids, 2004–2011
-
Maughan BC, Bachhuber MA, Mitra N, Starrels JL (2015). Prescription monitoring programs and emergency department visits involving opioids, 2004–2011. Drug Alcohol Depend 156: 282–288.
-
(2015)
Drug Alcohol Depend
, vol.156
, pp. 282-288
-
-
Maughan, B.C.1
Bachhuber, M.A.2
Mitra, N.3
Starrels, J.L.4
-
70
-
-
85018506438
-
-
[Online], (accessed October 26
-
Medscape Physician Compensation Report 2016. [Online] Available at: http://www.medscape.com/features/slideshow/compensation/2016/public/overview-page=1 (accessed October 26, 2016).
-
(2016)
Medscape Physician Compensation Report 2016
-
-
-
71
-
-
17844392070
-
Influence of psychotherapy attendance on buprenorphine treatment outcome
-
Montoya ID, Schroeder JR, Preston KL, Covi L, Umbricht A, Contoreggi C et al. (2005). Influence of psychotherapy attendance on buprenorphine treatment outcome. J Subst Abuse Treat 28: 247–254.
-
(2005)
J Subst Abuse Treat
, vol.28
, pp. 247-254
-
-
Montoya, I.D.1
Schroeder, J.R.2
Preston, K.L.3
Covi, L.4
Umbricht, A.5
Contoreggi, C.6
-
72
-
-
84928800803
-
The promises and pitfalls of digital technology in its application to alcohol treatment
-
Muench F (2014). The promises and pitfalls of digital technology in its application to alcohol treatment. Alcohol Res 36: 131–142.
-
(2014)
Alcohol Res
, vol.36
, pp. 131-142
-
-
Muench, F.1
-
73
-
-
1642285946
-
Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain
-
Narita M, Suzuki M, Imai S, Narita M, Ozaki S, Kishimoto Y et al. (2004). Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain. Life Sci 74: 2655–2673.
-
(2004)
Life Sci
, vol.74
, pp. 2655-2673
-
-
Narita, M.1
Suzuki, M.2
Imai, S.3
Narita, M.4
Ozaki, S.5
Kishimoto, Y.6
-
74
-
-
84964567818
-
-
[Online], (accessed January 16
-
National Heroin Threat Assessment Summary. [Online] Available at: https://www.dea.gov/divisions/hq/2016/hq062716_attach.pdf (accessed January 16, 2017d).
-
(2017)
National Heroin Threat Assessment Summary
-
-
-
75
-
-
84874444262
-
Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry
-
Navratilova E, Xie JY, Okun A, Qu C, Eyde N, Ci S et al. (2012). Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci U S A 109: 20709–20713.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 20709-20713
-
-
Navratilova, E.1
Xie, J.Y.2
Okun, A.3
Qu, C.4
Eyde, N.5
Ci, S.6
-
76
-
-
84938635051
-
Evidence of CNIH3 involvement in opioid dependence
-
Nelson EC, Agrawal A, Heath AC, Bogdan R, Sherva R, Zhang B et al. (2016). Evidence of CNIH3 involvement in opioid dependence. Mol Psychiatry 21: 608–614.
-
(2016)
Mol Psychiatry
, vol.21
, pp. 608-614
-
-
Nelson, E.C.1
Agrawal, A.2
Heath, A.C.3
Bogdan, R.4
Sherva, R.5
Zhang, B.6
-
77
-
-
77954029811
-
Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission
-
Niikura K, Narita M, Butelman ER, Kreek MJ, Suzuki T (2010). Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. Trends Pharmacol Sci 31: 299–305.
-
(2010)
Trends Pharmacol Sci
, vol.31
, pp. 299-305
-
-
Niikura, K.1
Narita, M.2
Butelman, E.R.3
Kreek, M.J.4
Suzuki, T.5
-
78
-
-
84979684903
-
Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication
-
Nikulina V, Guarino H, Acosta MC, Marsch LA, Syckes C, Moore SK et al. (2016). Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication. Pain 157: 1791–1798.
-
(2016)
Pain
, vol.157
, pp. 1791-1798
-
-
Nikulina, V.1
Guarino, H.2
Acosta, M.C.3
Marsch, L.A.4
Syckes, C.5
Moore, S.K.6
-
79
-
-
84868204703
-
Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse
-
Novy DM, Lam C, Gritz ER, Hernandez M, Driver LC, Koyyalagunta D (2012). Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse. J Pain 13: 1058–1067.
-
(2012)
J Pain
, vol.13
, pp. 1058-1067
-
-
Novy, D.M.1
Lam, C.2
Gritz, E.R.3
Hernandez, M.4
Driver, L.C.5
Koyyalagunta, D.6
-
80
-
-
84877073812
-
A population pharmacokinetic and pharmacodynamic study of a peripheral kappa-opioid receptor agonist CR665 and oxycodone
-
Olesen AE, Kristensen K, Staahl C, Kell S, Wong GY, Arendt-Nielsen L et al. (2013). A population pharmacokinetic and pharmacodynamic study of a peripheral kappa-opioid receptor agonist CR665 and oxycodone. Clin Pharmacokinet 52: 125–137.
-
(2013)
Clin Pharmacokinet
, vol.52
, pp. 125-137
-
-
Olesen, A.E.1
Kristensen, K.2
Staahl, C.3
Kell, S.4
Wong, G.Y.5
Arendt-Nielsen, L.6
-
81
-
-
84980368213
-
Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates
-
Patrick SW, Fry CE, Jones TF, Buntin MB (2016). Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff (Millwood) 35: 1324–1332.
-
(2016)
Health Aff (Millwood)
, vol.35
, pp. 1324-1332
-
-
Patrick, S.W.1
Fry, C.E.2
Jones, T.F.3
Buntin, M.B.4
-
82
-
-
79955927958
-
Prescription drug monitoring programs and death rates from drug overdose
-
Paulozzi LJ, Kilbourne EM, Desai HA (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain Med 12: 747–754.
-
(2011)
Pain Med
, vol.12
, pp. 747-754
-
-
Paulozzi, L.J.1
Kilbourne, E.M.2
Desai, H.A.3
-
83
-
-
84903692269
-
Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines – United States, 2012
-
Paulozzi LJ, Mack KA, Hockenberry JM, Division of Unintentional Injury Prevention NCfIP, Control CDC (2014). Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines – United States, 2012. MMWR Morb Mortal Wkly Rep 63: 563–568.
-
(2014)
MMWR Morb Mortal Wkly Rep
, vol.63
, pp. 563-568
-
-
Paulozzi, L.J.1
Mack, K.A.2
Hockenberry, J.M.3
-
84
-
-
85018506438
-
-
[Online], (accessed 10/26/16)
-
Peckham C (2016). Medscape Physician Compensation Report 2016. [Online] Available at: http://www.medscape.com/features/slideshow/compensation/2016/public/overview#page=1 (accessed 10/26/16).
-
(2016)
Medscape Physician Compensation Report 2016
-
-
Peckham, C.1
-
85
-
-
84880991284
-
Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry
-
Peles E, Schreiber S, Adelson M (2013). Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry. J Addict Med 7: 177–182.
-
(2013)
J Addict Med
, vol.7
, pp. 177-182
-
-
Peles, E.1
Schreiber, S.2
Adelson, M.3
-
86
-
-
84891802432
-
Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference
-
Portugal GS, Al-Hasani R, Fakira AK, Gonzalez-Romero JL, Melyan Z, McCall JG et al. (2014). Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference. J Neurosci 34: 527–538.
-
(2014)
J Neurosci
, vol.34
, pp. 527-538
-
-
Portugal, G.S.1
Al-Hasani, R.2
Fakira, A.K.3
Gonzalez-Romero, J.L.4
Melyan, Z.5
McCall, J.G.6
-
87
-
-
85048951452
-
-
[Online], (accessed 1/10/
-
Post Market Drug Safety Information for Patients and Providers. [Online] Available at: http://www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm191533.pdf (accessed 1/10/ 2017e).
-
(2017)
Post Market Drug Safety Information for Patients and Providers
-
-
-
90
-
-
84937643406
-
-
[Online], (accessed 1/16/17)
-
Prescription Drug Monitoring Program Center of Excellence at Brandeis (2014). Briefing on PDMP Effectiveness. [Online] Available at: http://www.pdmpassist.org/pdf/COE_documents/Add_to_TTAC/Briefing%20on%20PDMP%20Effectiveness%203rd%20revision.pdf (accessed 1/16/17).
-
(2014)
Briefing on PDMP Effectiveness
-
-
-
91
-
-
29844446057
-
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
-
Roberts JD, Gennings C, Shih M (2006). Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. Eur J Pharmacol 530: 54–58.
-
(2006)
Eur J Pharmacol
, vol.530
, pp. 54-58
-
-
Roberts, J.D.1
Gennings, C.2
Shih, M.3
-
92
-
-
0034812232
-
Screening for problematic prescription opioid use
-
Robinson RC, Gatchel RJ, Polatin P, Deschner M, Noe C, Gajraj N (2001). Screening for problematic prescription opioid use. Clin J Pain 17: 220–228.
-
(2001)
Clin J Pain
, vol.17
, pp. 220-228
-
-
Robinson, R.C.1
Gatchel, R.J.2
Polatin, P.3
Deschner, M.4
Noe, C.5
Gajraj, N.6
-
93
-
-
0038655485
-
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
-
Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 289: 2370–2378.
-
(2003)
JAMA
, vol.289
, pp. 2370-2378
-
-
Rosenblum, A.1
Joseph, H.2
Fong, C.3
Kipnis, S.4
Cleland, C.5
Portenoy, R.K.6
-
94
-
-
70349792617
-
The neurobiology of addictive disorders
-
Ross S, Peselow E (2009). The neurobiology of addictive disorders. Clin Neuropharmacol 32: 269–276.
-
(2009)
Clin Neuropharmacol
, vol.32
, pp. 269-276
-
-
Ross, S.1
Peselow, E.2
-
95
-
-
85008235154
-
Increases in drug and opioid-involved overdose deaths – United States, 2010–2015
-
Rudd RA, Seth P, David F, Scholl L (2016). Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. MMWR Morb Mortal Wkly Rep 65: 1445–1452.
-
(2016)
MMWR Morb Mortal Wkly Rep
, vol.65
, pp. 1445-1452
-
-
Rudd, R.A.1
Seth, P.2
David, F.3
Scholl, L.4
-
96
-
-
84931576945
-
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
-
Sakin YS, Dogrul A, Ilkaya F, Seyrek M, Ulas UH, Gulsen M et al. (2015). The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents. Neurogastroenterol Motil 27: 936–944.
-
(2015)
Neurogastroenterol Motil
, vol.27
, pp. 936-944
-
-
Sakin, Y.S.1
Dogrul, A.2
Ilkaya, F.3
Seyrek, M.4
Ulas, U.H.5
Gulsen, M.6
-
98
-
-
84881367408
-
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal
-
Scavone JL, Sterling RC, Van Bockstaele EJ (2013). Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal. Neuroscience 248: 637–654.
-
(2013)
Neuroscience
, vol.248
, pp. 637-654
-
-
Scavone, J.L.1
Sterling, R.C.2
Van Bockstaele, E.J.3
-
99
-
-
84988938832
-
Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study
-
Schrepf A, Harper DE, Harte SE, Wang H, Ichesco E, Hampson JP et al. (2016). Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain 157: 2217–2225.
-
(2016)
Pain
, vol.157
, pp. 2217-2225
-
-
Schrepf, A.1
Harper, D.E.2
Harte, S.E.3
Wang, H.4
Ichesco, E.5
Hampson, J.P.6
-
100
-
-
34548483418
-
Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors
-
Smith PA, Selley DE, Sim-Selley LJ, Welch SP (2007). Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors. Eur J Pharmacol 571: 129–137.
-
(2007)
Eur J Pharmacol
, vol.571
, pp. 129-137
-
-
Smith, P.A.1
Selley, D.E.2
Sim-Selley, L.J.3
Welch, S.P.4
-
101
-
-
84976865494
-
The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
-
Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
-
(2016)
Nucl Acids Res
, vol.44
, pp. D1054-D1068
-
-
Southan, C.1
Sharman, J.L.2
Benson, H.E.3
Faccenda, E.4
Pawson, A.J.5
Alexander, S.P.6
-
102
-
-
77955912822
-
Internet-based interventions for young people with problematic substance use: a systematic review
-
Tait RJ, Christensen H (2010). Internet-based interventions for young people with problematic substance use: a systematic review. Med J Aust 192: S15–S21.
-
(2010)
Med J Aust
, vol.192
, pp. S15-S21
-
-
Tait, R.J.1
Christensen, H.2
-
103
-
-
84930446191
-
Microglia disrupt mesolimbic reward circuitry in chronic pain
-
Taylor AM, Castonguay A, Taylor AJ, Murphy NP, Ghogha A, Cook C et al. (2015). Microglia disrupt mesolimbic reward circuitry in chronic pain. J Neurosci 35: 8442–8450.
-
(2015)
J Neurosci
, vol.35
, pp. 8442-8450
-
-
Taylor, A.M.1
Castonguay, A.2
Taylor, A.J.3
Murphy, N.P.4
Ghogha, A.5
Cook, C.6
-
105
-
-
66249125042
-
Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning
-
Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, de Lecea L et al. (2009). Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324: 1080–1084.
-
(2009)
Science
, vol.324
, pp. 1080-1084
-
-
Tsai, H.C.1
Zhang, F.2
Adamantidis, A.3
Stuber, G.D.4
Bonci, A.5
de Lecea, L.6
-
106
-
-
52349113159
-
Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders
-
Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC et al. (2008). Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 9: 883–891.
-
(2008)
J Pain
, vol.9
, pp. 883-891
-
-
Tsang, A.1
Von Korff, M.2
Lee, S.3
Alonso, J.4
Karam, E.5
Angermeyer, M.C.6
-
107
-
-
49649108910
-
Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis
-
Turk DC, Swanson KS, Gatchel RJ (2008). Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 24: 497–508.
-
(2008)
Clin J Pain
, vol.24
, pp. 497-508
-
-
Turk, D.C.1
Swanson, K.S.2
Gatchel, R.J.3
-
108
-
-
85010212721
-
-
[Online], (accessed 1/16/17)
-
US Drug Enforcement Agency (2016). National Heroin Threat Assessment Summary. [Online] Available at: https://www.dea.gov/divisions/hq/2016/hq062716_attach.pdf (accessed 1/16/17).
-
(2016)
National Heroin Threat Assessment Summary
-
-
-
110
-
-
0028953712
-
Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey
-
Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB (1995). Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 52: 219–229.
-
(1995)
Arch Gen Psychiatry
, vol.52
, pp. 219-229
-
-
Warner, L.A.1
Kessler, R.C.2
Hughes, M.3
Anthony, J.C.4
Nelson, C.B.5
-
111
-
-
67649216578
-
Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?
-
Wasan AD, Butler SF, Budman SH, Fernandez K, Weiss RD, Greenfield SF et al. (2009). Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 25: 193–198.
-
(2009)
Clin J Pain
, vol.25
, pp. 193-198
-
-
Wasan, A.D.1
Butler, S.F.2
Budman, S.H.3
Fernandez, K.4
Weiss, R.D.5
Greenfield, S.F.6
-
112
-
-
84994571368
-
Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis
-
West CP, Dyrbye LN, Erwin PJ, Shanafelt TD (2016). Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis. Lancet 388: 2272–2281.
-
(2016)
Lancet
, vol.388
, pp. 2272-2281
-
-
West, C.P.1
Dyrbye, L.N.2
Erwin, P.J.3
Shanafelt, T.D.4
-
113
-
-
85006783267
-
The endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
-
Wilkerson JL, Ghosh S, Mustafa M, Abdullah RA, Niphakis MJ, Cabrera R et al. (2017). The endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. Neuropharmacology 114: 156–167.
-
(2017)
Neuropharmacology
, vol.114
, pp. 156-167
-
-
Wilkerson, J.L.1
Ghosh, S.2
Mustafa, M.3
Abdullah, R.A.4
Niphakis, M.J.5
Cabrera, R.6
-
115
-
-
41949084994
-
Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors
-
Xiao C, Ye JH (2008). Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors. Neuroscience 153: 240–248.
-
(2008)
Neuroscience
, vol.153
, pp. 240-248
-
-
Xiao, C.1
Ye, J.H.2
-
116
-
-
84947760027
-
Mindfulness meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia
-
Zeidan F, Emerson NM, Farris SR, Ray JN, Jung Y, McHaffie JG et al. (2015). Mindfulness meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia. J Neurosci 35: 15307–15325.
-
(2015)
J Neurosci
, vol.35
, pp. 15307-15325
-
-
Zeidan, F.1
Emerson, N.M.2
Farris, S.R.3
Ray, J.N.4
Jung, Y.5
McHaffie, J.G.6
|